Cancer Conversations Podcast – Episode #4: The Latest Research in Multiple Myeloma and Leukemia

Matthew Davids

Matthew Davids, MD, of Dana-Farber’s Hematologic Oncology Treatment Center.

With new research in immunotherapy and targeted therapy, treatment options for blood cancer patients are rapidly expanding. Combination therapies have also caused much excitement among researchers and physicians, and ongoing clinical trials are continuing to look at new strategies that use multiple drugs for fighting these diseases.

In this Cancer Conversations podcast episode, Irene Ghobrial, MD, and Matthew Davids, MD, of Dana-Farber’s Hematologic Oncology Treatment Center, discuss some of these new treatments and clinical trials for multiple myeloma, leukemia and other blood cancers.

Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play and RSS.

The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes.

Learn more about Dana-Farber’s Cancer Podcast Series.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Latest Tweets

Dana-Farber @danafarber
CRISPR, a powerful tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/5WZMiG3WtG
Dana-Farber @danafarber
“This is only the beginning of the era of cancer #immunology,” says Dana-Farber's @OsamaRahma2. “It will only expan… https://t.co/dXrNZf06sJ
Dana-Farber @danafarber
What's the connection between #coloncancer and nuts? Research shows that consuming nuts reduces the risk of colon c… https://t.co/lzw1MzuOZk

Patient and Family Blogs

Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.

Here are some blogs that you can follow.